Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/07/070696
CTRI/2024/07/070696
Not yet recruiting
未知

A comparative study to evaluate the efficacy and safety of rosuvastatin or in combination of rosuvastatin with fenofibrate in patients with dyslipidemia at tertiary care centre. - NI

Dr Shivam Yadav0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E785- Hyperlipidemia, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Sponsor
Dr Shivam Yadav
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Shivam Yadav

Eligibility Criteria

Inclusion Criteria

  • •Either gender aged 18 to 70 years .
  • •Patients giving written informed consent will be taken.
  • •Hypertensive patients.

Exclusion Criteria

  • •Patient not willing to participate in the study.
  • •Active liver disease.
  • •Preexisting gallbladder disease.
  • •Type 1 diabetes mellitus.
  • •Thyroid dysfunction.
  • •Type 2 diabetes mellitus.
  • •Any malignancies.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Efficacy of oral tranexamic acid and topical triple combination cream in treatment of melasmaHealth Condition 1: L814- Other melanin hyperpigmentation
CTRI/2024/04/065382MOHAN H
Not yet recruiting
Not Applicable
Comparison of efficacy and safety of Vortioxetine and Escitalopram in depressive patients.Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
CTRI/2023/12/060661Ronakkumar Chandubhai Patel
Not yet recruiting
Not Applicable
Iron deficiency anemia treatment in adults: comparing daily versus alternate day iron regimens
CTRI/2024/03/064861Viswanathan S
Not yet recruiting
Not Applicable
A study to compare two drugs Seratconazole versus Luliconacole for improvement of symptoms and to compare the side effectsHealth Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2022/10/046157Yuvarani R
Not yet recruiting
Not Applicable
Comparison study to evaluate the efficacy and safety of a topical gel
CTRI/2024/08/072002Abbott India Limited